Loading company details...
Latest Form 4 (Aug 12, 2026): Dietrich John Pauls (President & CEO): Grant/Award of 60,200 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Dietrich John Pauls, President & CEO | Grant/Award | 60,200 | n/a |
| Jun 3, 2026 | Randall Michael Giuffre | Grant/Award | 40,412 | n/a |
| Jun 3, 2026 | Richard Kuntz | Grant/Award | 40,412 | n/a |
| Jun 3, 2026 | Daniel J. O'Connor | Grant/Award | 40,412 | n/a |
| Jun 3, 2026 | Tanya Lewis | Grant/Award | 40,412 | n/a |
| Jun 3, 2026 | Charles Pauling Semba | Grant/Award | 40,412 | n/a |
| Jun 3, 2026 | James T. Parsons | Grant/Award | 51,189 | n/a |
| Jun 3, 2026 | Dietrich John Pauls, President & CEO | Grant/Award | 380,000 | n/a |
| Jun 3, 2026 | Scott Kellen, CFO & Secretary | Grant/Award | 162,000 | n/a |
| Jun 3, 2026 | Julie Krop, Chief Medical Officer | Grant/Award | 67,500 | n/a |